International Business

R&D pipeline

Drug pipeline

Therapeutic field
  • project name Indications Pre-clinical Phase I Phase II Phase III NDA Approval
Cardiovascular and related
  •  Xinlitan (Allisartan Isoproxil Tablets) Hypertension
  • Enaro® (Enarodustat Tablets) Renal Anemia
  • Fulitan® (Allisartan Isoproxil and Amlodipine Tablets) Hypertension
  • Xinchaotuo(Sacubitril Allisartan Calcium Tablets) Hypertension
  • SAL086
    (Sacubitril Allisartan Calcium Tablets)
    Chronic Heart Failure
  • Fulian® (Allisartan Isoproxil and Indapamide Sustained-release Tablets) Hypertension
  • SAL0130 Hypertension
  • SAL0951 CIA
  • SAL0120 Hypertension/CKD
  • SAL0140 Hypertension/CKD/PA
  • SAL0132 Hypertension
  • SAL0137 Dyslipidemia
  • SAL0139 Dyslipidemia
  • SAL0144 Dyslipidemia
  • SAL0147 IgA Nephropathy
  • SAL0127
    Thrombosis
  • SAL003 Hypercholesterolemia
  • SAL007
    (China + USA)
    Chronic Heart Failure
  • SAL061 Dyslipidemia
Metabolism
  • Xinlitin (Fultagliptin Benzoate Tablets) Diabetes
  • SAL0112 Diabetes/Obesity
  • SAL0125 Diabetes/Obesity/ MASH
  • SAL0150 Diabetes/Overweight/ Obesity
  • SAL0145 MASH
  • SAL073 Diabetes/Obesity
Orthopaedics
  • Xinfutai® (Recombinant Teriparatide for Injection) Osteoporosis
  • Xinfutai Pro® (Teriparatide Injection) Osteoporosis
  • SAL056 Osteoporosis
  • SAL023 Osteoporosis
Oncology
  • SAL006 Tumor
  • SAL012 Tumor
Others
  • SAL0114 Depression/AD Agitation
  • SAL0119
    (China + USA)
    Rheumatoid Arthritis
  • Chemical Drugs
  • Biologics